StonvexLoading…
StonvexStonvexStonvexCore line items from UDMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $789.84M | $786.57M | $728.94M | $629.10M |
Operating Income | $-4.16M | $-89.33M | $-121.89M | $-151.19M |
Net Income | $3.81M | $-85.29M | $-107.29M | $-153.88M |
EPS (Diluted) | $0.03 | $-0.56 | $-0.71 | $-1.09 |
Total Assets | $617.70M | $605.63M | $741.20M | $737.57M |
Total Liabilities | $407.24M | $408.23M | $384.30M | $398.26M |
Cash & Equivalents | $231.49M | $190.59M | $305.56M | $313.69M |
Free Cash Flow OCF − CapEx | $81.86M | $50.74M | $-2.64M | $-62.52M |
Shares Outstanding | 145.05M | 147.48M | 157.17M | 145.01M |